New Diagnostic Method Aims to Pinpoint Problematic Gut Bacteria in Inflammatory Bowel Disease
Researchers have developed a technique to identify specific bacteria that drive chronic gut inflammation, opening the door to targeted treatments for Crohn's disease and ulcerative colitis.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Researchers identified two bacterial species, Sarcina perfringens and Hathewaya massiliensis, linked to intestinal inflammation.
- A screening of 1,518 compounds found five substances that selectively inhibit these bacteria without harming the broader microbiome.
- The method requires further clinical trials in humans to confirm its safety and therapeutic efficacy.
An international team of scientists has unveiled a novel approach designed to detect and selectively inhibit gut bacteria responsible for triggering or worsening chronic intestinal inflammation. Published in the journal Gut, the work was led by Dr. Lukas Mager from University Hospital Tübingen alongside Prof. Kathy McCoy of the University of Calgary. The findings suggest a potential shift toward personalized medicine for inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, where patient microbiomes vary significantly and determining whether specific microbes cause disease or merely react to it remains challenging.
To pinpoint disease-promoting organisms, the researchers analyzed stool samples from patients before and after medical interventions like antibiotics or fecal microbiota transplantation. By transferring these microorganisms into germ-free mice and utilizing host immune antibodies to isolate harmful strains, the team identified two specific bacterial species—Sarcina perfringens and Hathewaya massiliensis—that stimulate innate immune cells and provoke inflammation. Further analysis revealed elevated levels of Sarcina perfringens in about 25% to 30% of IBD patients, while Hathewaya massiliensis was elevated in roughly 5%. Laboratory tests using human intestinal organoids confirmed that both species can impair intestinal epithelial cell function.
What to know: The study also screened over 1,500 approved compounds and discovered five substances that selectively inhibit the growth of these two harmful species without disrupting the broader microbiome. Notably, the antibiotic oxolinic acid reduced inflammation in mouse models comparably to broad-spectrum treatments while preserving beneficial microbes. Because these findings are currently based on animal models and laboratory tissue tests, further clinical research is required to determine safety and efficacy in humans. Readers should consult a physician for any personal medical decisions regarding IBD care.
Source Medical Xpress — medicalxpress.com/news/2026-11-personalized-therapies-crohn-ulcerative-… ↗
Read next
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…